KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort
- PMID: 29280757
- DOI: 10.1097/QAD.0000000000001735
KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort
Abstract
Objective: To determine the associations of KIR3DL1/S1(3DL1/S1) and its epistatic interactions with human leukocyte antigen class I (HLA-I) alleles with resistance and susceptibility to HIV-1.
Design: Despite repeated exposure to HIV-1, a subset of women enrolled in the Pumwani sex worker cohort remain HIV uninfected. Previous studies have shown that specific HLA class I and II alleles were associated with this natural immunity. In this study, we investigated the association of 3DL1/S1 and its epistatic interactions with HLA-I, with resistance or susceptibility to HIV-1 acquisition.
Methods: We used a sequence-based typing method to genotype 3DL1/S1 of 641 women in this cohort. The association of 3DL1/S1 and its epistatic interactions with HLA-I were analyzed using SPSS statistics software.
Results: 3DL1041 is enriched in the HIV-1-resistant women [P = 0.009, Pc = 0.0468, odds ratio (OR): 3.359, 95% confidence interval (CI): 1.39-8.32], whereas, 3DL1020 was associated with susceptibility to HIV-1 infection before correction for multiple comparisons (P = 0.029, Pc = 0.0858, OR: 0.316, 95%CI: 0.10-1.04). Epistatic interactions between several 3DL1 alleles and specific HLA-I alleles were observed. Among them the cocarriage of 3DL1041 with Bw4 (P = 1E - 05, Pc = 0.0015, OR: 13.33, 95%CI: 3.43-51.9), or Bw6 (P = 0.008, Pc = 0.272, OR: 3.92, 95%CI: 1.51-10.17), increased the odds of remaining HIV-1 uninfected. Further, 3DL1041+/Bw4+ women who entered the cohort HIV negative remained uninfected (P = 0.032, Pc = 0.0858). Cocarriage of 3DL101501 with C02 : 10 (P = 2.73E - 07, Pc = 7.0954E - 06), B15 : 03 (P = 3.21E - 04, Pc = 0.0042), A24 supertype (P = 8.89E - 04, Pc = 0.0077), or A23 : 01 (P = 0.0036, Pc = 0.0236) was associated with increased susceptibility to seroconversion.
Conclusion: The effects of interactions between 3DL1 and HLA-I alleles on resistance/susceptibility to HIV-1 infection suggest that innate immunity plays an important role in HIV-1 acquisition and should be studied and explored for HIV prevention.
Similar articles
-
Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.AIDS. 2018 Nov 28;32(18):2679-2688. doi: 10.1097/QAD.0000000000002028. AIDS. 2018. PMID: 30289808
-
A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.AIDS. 2008 Jul 31;22(12):1487-91. doi: 10.1097/QAD.0b013e3282ffde7e. AIDS. 2008. PMID: 18614872
-
Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort.AIDS. 2013 Jan 2;27(1):7-15. doi: 10.1097/QAD.0b013e32835ab1f2. AIDS. 2013. PMID: 23032415
-
Variable NK cell receptors exemplified by human KIR3DL1/S1.J Immunol. 2011 Jul 1;187(1):11-9. doi: 10.4049/jimmunol.0902332. J Immunol. 2011. PMID: 21690332 Free PMC article. Review.
-
Natural Immunity against HIV-1: Progression of Understanding after Association Studies.Viruses. 2022 Jun 8;14(6):1243. doi: 10.3390/v14061243. Viruses. 2022. PMID: 35746714 Free PMC article. Review.
Cited by
-
Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.PLoS Comput Biol. 2022 Feb 22;18(2):e1009059. doi: 10.1371/journal.pcbi.1009059. eCollection 2022 Feb. PLoS Comput Biol. 2022. PMID: 35192601 Free PMC article.
-
Human NK cells confer protection against HIV-1 infection in humanized mice.J Clin Invest. 2022 Dec 15;132(24):e162694. doi: 10.1172/JCI162694. J Clin Invest. 2022. PMID: 36282589 Free PMC article.
-
Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation.Cancers (Basel). 2023 May 13;15(10):2754. doi: 10.3390/cancers15102754. Cancers (Basel). 2023. PMID: 37345091 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials